https://www.selleckchem.com/pr....oducts/Triciribine.h
The median overall survival was 7 months. The 1-, 2-, and 5-year survival rates were 29%, 21.5%, and 4.6%, respectively. The age of 60 years was a significant poor prognostic factor. In addition, patients who received combined treatment exhibited the highest survival rate. PCNSL has a low survival rate, even in the present era. Older age is the most substantial factor associated with unfavorable outcomes. The most effective treatment is combined with WBRT and CMT. PCNSL has a low survival rate, even in the present era. Older age
Like
Comment
Share
